Regeneron joins companies offering most-favored-nation drug pricing
Regeneron has agreed to offer some of its medications at most-favored-nation prices under a deal with the administration.
Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of its drugs at most-favored-nation pricing. The agreement places Regeneron alongside other drugmakers participating in the administration’s pricing program.